QGEN
Qiagen NVNYSEHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$8.50B
P/E Ratio
19.65
EPS
$2.10
Beta
0.79
52W High
$57.82
52W Low
$37.77
50-Day MA
$46.46
200-Day MA
$47.05
Dividend Yield
0.66%
Profit Margin
20.30%
Forward P/E
12.82
PEG Ratio
1.03
About Qiagen NV
QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. The company is headquartered in Venlo, the Netherlands.
Fundamentals
| Revenue (TTM) | $2.09B |
| Gross Profit (TTM) | $1.39B |
| EBITDA | $728.29M |
| Operating Margin | 27.40% |
| Return on Equity | 11.60% |
| Return on Assets | 5.77% |
| Revenue/Share (TTM) | $10.13 |
| Book Value | $18.33 |
| Price-to-Book | 2.22 |
| Price-to-Sales (TTM) | 4.07 |
| EV/Revenue | 4.362 |
| EV/EBITDA | 12.71 |
| Quarterly Earnings Growth (YoY) | 21.90% |
| Quarterly Revenue Growth (YoY) | 3.70% |
| Shares Outstanding | $206.07M |
| Float | $204.12M |
| % Insiders | 2.31% |
| % Institutions | 79.00% |
Analyst Ratings
Consensus ($55.46 target)
3
Strong Buy3
Buy11
HoldData last updated: 4/9/2026